Hao Zhu Selected Research

2,4-dimethylpyrrole

9/2014

An "enhanced PET"-based fluorescent probe with ultrasensitivity for imaging basal and elesclomol-induced HClO in cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hao Zhu Research Topics

Disease

58	Neoplasms (Cancer) 05/2022 - 09/2011
11	Carcinogenesis 12/2021 - 05/2014
9	Hypertension (High Blood Pressure) 01/2022 - 04/2014
9	Schizophrenia (Dementia Praecox) 01/2021 - 01/2015
9	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 09/2014
8	Myocardial Infarction 01/2021 - 10/2009
7	Hypoxia (Hypoxemia) 09/2022 - 01/2002
7	Inflammation (Inflammations) 05/2022 - 11/2013
6	Neoplasm Metastasis (Metastasis) 07/2022 - 12/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2016
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2013
5	Infections 01/2022 - 02/2016
5	Fibrosis (Cirrhosis) 01/2022 - 02/2016
5	Hyperglycemia 01/2022 - 07/2004
5	Diabetes Mellitus 01/2022 - 04/2014
5	Liver Neoplasms (Liver Cancer) 12/2021 - 01/2016
5	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019 - 11/2008
4	Body Weight (Weight, Body) 01/2022 - 01/2015
4	Liver Diseases (Liver Disease) 11/2020 - 11/2014
4	Polyploidy 01/2020 - 09/2014
3	Osteosarcoma (Osteogenic Sarcoma) 07/2022 - 12/2017
3	COVID-19 01/2022 - 12/2020
3	Ischemia 01/2022 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2014
3	Pain (Aches) 01/2022 - 05/2017
3	Wounds and Injuries (Trauma) 01/2022 - 10/2018
3	Stroke (Strokes) 07/2021 - 01/2016
3	Dyslipidemias (Dyslipidemia) 06/2021 - 04/2014
3	Death (Near-Death Experience) 01/2021 - 09/2013
3	Insulin Resistance 01/2019 - 07/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 03/2014
3	Thrombosis (Thrombus) 01/2018 - 09/2013
3	Atherosclerosis 11/2017 - 04/2014
3	Acute Coronary Syndrome 11/2015 - 04/2014
3	Experimental Arthritis 01/2014 - 11/2012
2	Pulmonary Hypertension 09/2022 - 07/2022
2	Vascular Remodeling 09/2022 - 07/2022
2	Glioma (Gliomas) 01/2022 - 01/2017
2	Atrial Fibrillation 01/2022 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2011
2	Osteoarthritis 12/2021 - 01/2020
2	Emergence Delirium 11/2021 - 01/2015
2	Respiratory Insufficiency (Respiratory Failure) 11/2021 - 01/2020
2	Rupture 07/2021 - 03/2019
2	Pneumonia (Pneumonitis) 07/2021 - 07/2020

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2022 - 07/2012
10	Biological ProductsIBA 12/2021 - 11/2004
10	Proteins (Proteins, Gene)FDA Link 04/2020 - 04/2005
9	MicroRNAs (MicroRNA)IBA 07/2020 - 09/2011
6	Long Noncoding RNAIBA 07/2022 - 01/2018
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 07/2008
6	Small Interfering RNA (siRNA)IBA 11/2018 - 08/2014
5	RNA (Ribonucleic Acid)IBA 07/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 05/2022 - 03/2016
5	LipidsIBA 01/2022 - 01/2019
5	CytokinesIBA 01/2021 - 01/2014
5	oxidized low density lipoproteinIBA 10/2020 - 04/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	Insulin (Novolin)FDA Link 10/2021 - 07/2004
4	Dizocilpine Maleate (Dizocilpine)IBA 01/2021 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 07/2010
4	Caspase 3 (Caspase-3)IBA 01/2020 - 07/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2017
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 07/2012
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 11/2015
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 01/2015
3	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2019
3	N-Methylaspartate (NMDA)IBA 01/2021 - 01/2015
3	IronIBA 01/2021 - 04/2014
3	EnzymesIBA 01/2021 - 02/2016
3	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2020 - 01/2018
3	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 11/2020 - 01/2018
3	LDL CholesterolIBA 10/2020 - 04/2014
3	Transcription Factors (Transcription Factor)IBA 04/2020 - 01/2002
3	CateninsIBA 01/2020 - 09/2014
3	Blood Glucose (Blood Sugar)IBA 02/2019 - 07/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 09/2014
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 05/2015 - 09/2011
3	Fluorescent Dyes (Fluorescent Probes)IBA 01/2015 - 07/2012
2	astragaloside AIBA 09/2022 - 07/2022
2	LipopolysaccharidesIBA 05/2022 - 01/2020
2	Adalimumab (Humira)FDA Link 01/2022 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 09/2014
2	VaccinesIBA 12/2021 - 03/2014
2	Sorafenib (BAY 43-9006)FDA Link 12/2021 - 10/2019
2	Dexmedetomidine FDA Link 11/2021 - 01/2015
2	Propofol (Diprivan)FDA LinkGeneric 11/2021 - 01/2015
2	SaltsIBA 11/2021 - 10/2018
2	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2021 - 01/2020
2	BenzodiazepinesIBA 11/2021 - 01/2020
2	Carbon DioxideIBA 11/2021 - 01/2020
2	Diazepam (Valium)FDA LinkGeneric 11/2021 - 01/2020
2	Oxycodone (Oxycontin)FDA LinkGeneric 11/2021 - 01/2020

Therapy/Procedure

20	Therapeutics 07/2022 - 04/2014
4	Percutaneous Coronary Intervention 01/2022 - 09/2013
3	Liver Transplantation 01/2022 - 01/2019
3	Stents 01/2018 - 09/2013
2	Drug Therapy (Chemotherapy) 07/2021 - 01/2021